Home LiteratureArticle Details
PMID: 8301764 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.

JAMA ·Vol. 271 ·No. 7 ·1994-02-16 ·Pages 507-14

Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, Staley LW, Hagerman RJ

Abstract

Fragile X syndrome is caused by a mutation involving expansion of a CGG trinucleotide repeat segment in the fragile X mental retardation-1 (FMR1) gene on the long arm of the X chromosome. This study was undertaken to determine the relative impact of three molecular characteristics of the FMR1 mutation--number of CGG repeats, methylation status, and X inactivation ratio--on the cognitive involvement of female carriers of fragile X syndrome. Retrospective study with new DNA analysis of known female carriers of fragile X syndrome. Molecular studies were conducted in a university-based DNA diagnostic laboratory. Patients were originally ascertained through a regional fragile X clinic in a university-affiliated pediatric hospital. Forty-eight female carriers of fragile X syndrome were studied, including 22 with a premutation (a small expansion to approximately 50 to 200 CGG repeats), 23 with a full mutation (a full expansion to > 200 CGG repeats), and three with both types of mutations (mosaics). Median IQ score was significantly lower for females with a full mutation than for females with a premutation. No significant relationship was found between IQ score and number of CGG repeats or percentage methylation of the mutant allele within each mutation category. In addition, no significant relationship was found between IQ score and the proportion of normal FMR1 alleles on the active X chromosome in the carrier female group as a whole or in either mutation subgroup. Comparisons of leukocytes and saliva-borne epithelial cells in certain full-mutation carriers revealed striking differences in FMR1 mutation sizes. Mutation category remains the most important predictor of affectedness in female carriers of fragile X syndrome. Our data do not support use of the proportion of normal FMR1 alleles on the active X chromosome as a predictor of cognitive involvement in female carriers with full mutations. Individual tissue-specific differences exist in the heterogeneous sizes of full mutations and in the presence of premutation/full-mutation mosaicism.

Related Genes
MeSH Terms
Adolescent Adult Child Child, Preschool Cognition/physiology Cognition Disorders/diagnosis,etiology,genetics DNA/blood,genetics,physiology Female Fragile X Mental Retardation Protein Fragile X Syndrome/blood,genetics,pathology,physiopathology Heterozygote Humans Intelligence Tests Methylation Middle Aged Mutation/genetics,physiology Nerve Tissue Proteins/genetics,physiology Phenotype Predictive Value of Tests RNA-Binding Proteins Repetitive Sequences, Nucleic Acid/genetics,physiology Retrospective Studies Saliva/cytology Severity of Illness Index X Chromosome/physiology
Chemicals
FMR1 protein, human Nerve Tissue Proteins RNA-Binding Proteins Fragile X Mental Retardation Protein DNA
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Taylor A K
Department of Pediatrics, University of Colorado Health Sciences Center, Denver 80262.
Safanda J F
Fall M Z
Quince C
Lang K A
Hull C E
Carpenter I
Staley L W
Hagerman R J
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1994-02-16
Pages
507-14
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Grants
PHS HHS · MCJ000252 · United States
NIMH NIH HHS · MH45916 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com